VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
← Pulse/Companies

Serina Therapeutics on Pulse

Biotech

The full thread of our Serina Therapeutics coverage — a running record of every development we've tracked, with the VC take on each.

2
Stories
0
With a headline figure
Aug 24, 2026
Since

Coverage Timeline

newest first
  1. Aug 25, 2026IPOTwo More S-1s Land: Enhanced Group, Serina Therapeutics→
  2. Aug 24, 2026IPOSerina Therapeutics Files to Sell Shares for Parkinson's Drug→

All Coverage

IPO· Aug 25, 2026

Two More S-1s Land: Enhanced Group, Serina Therapeutics

Illustration for: Two More S-1s Land: Enhanced Group, Serina Therapeutics
IPO

Two More S-1s Land: Enhanced Group, Serina Therapeutics

Enhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.

Aug 25, 2026BY THE NUMBERS
IPO· Aug 24, 2026

Serina Therapeutics Files to Sell Shares for Parkinson's Drug

Illustration for: Serina Therapeutics Files to Sell Shares for Parkinson's Drug
IPO

Serina Therapeutics Files to Sell Shares for Parkinson's Drug

Biotech Serina Therapeutics filed an S-1 covering up to 12.5 million shares tied to a stock purchase agreement, funding continued development of its lead Parkinson's disease candidate SER-252 built on its POZ drug-delivery platform.

Aug 24, 2026DEEP DIVE
@Trace_Cohen·t@nyvp.com